In last trading session, TNF Pharmaceuticals Inc (NASDAQ:TNFA) saw 16.03 million shares changing hands with its beta currently measuring 1.84. Company’s recent per share price level of $0.09 trading at -$0.02 or -13.12% at ring of the bell on the day assigns it a market valuation of $1.35M. That closing price of TNFA’s stock is at a discount of -2300.0% from its 52-week high price of $2.16 and is indicating a discount of -11.11% from its 52-week low price of $0.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.34 million shares which gives us an average trading volume of 8.19 million if we extend that period to 3-months.
TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information
TNF Pharmaceuticals Inc’s shares saw a change of -94.77% in year-to-date performance and have moved -19.06% in past 5-day. TNF Pharmaceuticals Inc (NASDAQ:TNFA) showed a performance of -35.14% in past 30-days. Number of shares sold short was 3.6 million shares which calculate 0.46 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 50.65% during past 5 years.
TNF Pharmaceuticals Inc (NASDAQ:TNFA)’s Major holders
Insiders are in possession of 0.11% of company’s total shares while institution are holding 1.44 percent of that, with stock having share float percentage of 1.44%. Investors also watch the number of corporate investors in a company very closely, which is 1.44% institutions for TNF Pharmaceuticals Inc that are currently holding shares of the company. UBS GROUP AG is the top institutional holder at TNFA for having 15822.0 shares of worth $29112.0. And as of 2024-06-30, it was holding 0.6953 of the company’s outstanding shares.
The second largest institutional holder is GEODE CAPITAL MANAGEMENT, LLC, which was holding about 14410.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.6332 of outstanding shares, having a total worth of $26517.0.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of May 31, 2025 , the former fund manager was holding 21.64 shares of worth $2049.0 or 0.15% of the total outstanding shares. The later fund manager was in possession of 13.69 shares on Mar 31, 2025 , making its stake of worth around $1296.0 in the company or a holder of 0.10% of company’s stock.
